This study is in progress, not accepting new patients
Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants
Summary
- Eligibility
- for people ages 18-70 (full criteria)
- Location
- at Stanford, California and other locations
- Dates
- study startestimated completion
- Principal Investigator
- by Flavio Vincenti
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Flavio Vincenti
Professor, Medicine, School of Medicine. Authored (or co-authored) 274 research publications
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Medeor Therapeutics, Inc.
- ID
- NCT03363945
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- About 30 people participating
- Last Updated